Glaucoma in patients with ocular inflammatory disease

Ophthalmology Clinics of North America

Volumn 18, Issue 3, 2005, Pages 421-430

  Kuchtey, Rachel W ^a   Lowder, Careen Y ^a   Smith, Scott D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIFIBROTIC AGENT; ANTIHYPERTENSIVE AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMATOPROST; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DORZOLAMIDE; FLUOROURACIL; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; LATANOPROST; METIPRANOLOL; MIOTIC AGENT; MITOMYCIN C; PROSTAGLANDIN DERIVATIVE; TIMOLOL MALEATE; TISSUE PLASMINOGEN ACTIVATOR; TRAVOPROST; TRIAMCINOLONE ACETONIDE;

ANTERIOR EYE CHAMBER ANGLE; AQUEOUS HUMOR FLOW; CLINICAL TRIAL; CONJUNCTIVAL HYPEREMIA; CORNEA EDEMA; DISEASE CONTROL; DRUG CONTRAINDICATION; DRUG INDICATION; EYE COLOR; EYE INFLAMMATION; EYE TOXICITY; EYELASH; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; IMMUNOPATHOLOGY; IMPLANT; INFLAMMATORY DISEASE; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; IRIS DISEASE; JUVENILE RHEUMATOID ARTHRITIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OBSTRUCTION; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PUPIL DISEASE; RETINA MACULA CYSTOID EDEMA; REVIEW; SECONDARY GLAUCOMA; SIDE EFFECT; SURGICAL TECHNIQUE; TRABECULAR MESHWORK; TRABECULECTOMY; UVEITIC GLAUCOMA; UVEITIS; VALVE; VISCOCANALOSTOMY;

GLAUCOMA; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; UVEITIS;

EID: 23044451761     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ohc.2005.05.004     Document Type: Review

References (74)

1. H. Kok, and K. Barton Uveitic glaucoma Ophthalmol Clin North Am 15 3 2002 375 387
2. R.S. Moorthy, A. Mermoud, and G. Baerveldt Glaucoma associated with uveitis Surv Ophthalmol 41 5 1997 361 394
3. P. Neri, A. Azuara-Blanco, and J.V. Forrester Incidence of glaucoma in patients with uveitis J Glaucoma 13 6 2004 461 465
4. A.C. Westfall, A.K. Lauer, and E.B. Suhler Toxoplasmosis retinochoroiditis and elevated intraocular pressure: a retrospective study J Glaucoma 14 1 2005 3 10
5. U. Elgin, N. Berker, and A. Batman Incidence of secondary glaucoma in Behçet disease J Glaucoma 13 6 2004 441 444
6. C.S. Foster, K. Havrlikova, and S. Baltatzis Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocy is Acta Ophthalmol Scand 78 5 2000 576 579
7. K. Kotaniemi, H. Kautiainen, and A. Karma Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study Ophthalmology 108 11 2001 2071 2075
8. A. Rothova Medical treatment of cystoid macular edema Ocul Immunol Inflamm 10 4 2002 239 246
9. N.N. Markomichelakis, I. Halkiadakis, and E. Pantelia Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography Ophthalmology 111 5 2004 946 953
10. M.F. Estafanous, C.Y. Lowder, and P.K. Kaiser Patterns of macular edema in uveitis patients Ophthalmology 112 2 2005 360
11. K.D. Rosenberg, W.J. Feuer, and J.L. Davis Ocular complications of pediatric uveitis Ophthalmology 111 12 2004 2299 2306
12. M.C. Gillies, J.M. Simpson, and F.A. Billson Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial Arch Ophthalmol 122 3 2004 336 340
13. S.J. Bakri, and P.M. Beer The effect of intravitreal triamcinolone acetonide on intraocular pressure Ophthalmic Surg Lasers Imaging 34 5 2003 386 390
14. L.M. Smithen, M.D. Ober, and L. Maranan Intravitreal triamcinolone acetonide and intraocular pressure Am J Ophthalmol 138 5 2004 740 743
15. W. Grant Clinical measurements of aqueous outflow Arch Ophthalmol 46 1951 113 131
16. D.H. Johnson Human trabecular meshwork cell survival is dependent on perfusion rate Invest Ophthalmol Vis Sci 37 6 1996 1204 1208
17. R. Elliot A treatise on glaucoma 1918 Oxford Medical Publications London
18. J.S. Mo, M.G. Anderson, and M. Gregory By altering ocular immune privilege, bone marrow-derived cells pathogenically contribute to DBA/2J pigmentary glaucoma J Exp Med 197 10 2003 1335 1344
19. D. Wakefield, and A. Lloyd The role of cytokines in the pathogenesis of inflammatory eye disease Cytokine 4 1 1992 1 5
20. R.C. Tripathi, W.F. Chan, and J. Li Trabecular cells express the TGF-beta 2 gene and secrete the cytokine Exp Eye Res 58 5 1994 523 528
21. J.P. Alexander, J.R. Samples, and T.S. Acott Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression Curr Eye Res 17 3 1998 276 285
22. E.R. Tamm, P. Russell, and D.L. Epstein Modulation of myocilin/TIGR expression in human trabecular meshwork Invest Ophthalmol Vis Sci 40 11 1999 2577 2582
23. C.N. Nagineni, B. Detrick, and J.J. Hooks Transforming growth factor-beta expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: a possible role in the immunopathogenesis of retinochoroiditis Clin Exp Immunol 128 2 2002 372 378
24. R.C. Tripathi, J. Li, and W.F. Chan Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2 Exp Eye Res 59 6 1994 723 727
25. S.R. Planck, X.N. Huang, and J.E. Robertson Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment Invest Ophthalmol Vis Sci 35 3 1994 924 930
26. N. Wang, S.K. Chintala, and M.E. Fini Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype Nat Med 7 3 2001 304 309
27. B. Becker Intraocular pressure response to topical corticosteroids Invest Ophthalmol 26 1965 198 205
28. E.M. Stone, J.H. Fingert, and W.L. Alward Identification of a gene that causes primary open-angle glaucoma Science 275 5300 1997 668 670
29. W.L. Alward The genetics of open-angle glaucoma: the story of GLC1A and myocilin Eye 14 Pt 3B 2000 429 436
30. W.L. Alward, J.H. Fingert, and M.A. Coote Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A) N Engl J Med 338 15 1998 1022 1027
31. J.R. Polansky, D.J. Fauss, and P. Chen Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product Ophthalmologica 211 3 1997 126 139
32. J.H. Fingert, A.F. Clark, and J.E. Craig Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension Invest Ophthalmol Vis Sci 42 1 2001 145 152
33. I. Stoilov, A.N. Akarsu, and M. Sarfarazi Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome 2p21 Hum Mol Genet 6 4 1997 641 647
34. T. Borras Gene expression in the trabecular meshwork and the influence of intraocular pressure Prog Retin Eye Res 22 4 2003 435 463
35. R. Gerometta, S.M. Podos, and O.A. Candia Steroid-induced ocular hypertension in normal cattle Arch Ophthalmol 122 10 2004 1492 1497
36. D.A. Jabs, J.T. Rosenbaum, and C.S. Foster Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel Am J Ophthalmol 130 4 2000 492 513
37. G.N. Holland, and E.R. Stiehm Special considerations in the evaluation and management of uveitis in children Am J Ophthalmol 135 6 2003 867 878
38. E.M. Ceballos, A.D. Beck, and M.J. Lynn Trabeculectomy with antiproliferative agents in uveitic glaucoma J Glaucoma 11 3 2002 189 196
39. E.M. Ceballos, R.K. Parrish, and J.C. Schiffman Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma Ophthalmology 109 12 2002 2256 2260
40. A. Da Mata, S.E. Burk, and P.A. Netland Management of uveitic glaucoma with Ahmed glaucoma valve implantation Ophthalmology 106 11 1999 2168 2172
41. I.S. Yalvac, G. Sungur, and E. Turhan Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease J Glaucoma 13 6 2004 450 453
42. L.A. Lam, C.Y. Lowder, and G. Baerveldt Surgical management of cataracts in children with juvenile rheumatoid arthritis-associated uveitis Am J Ophthalmol 135 6 2003 772 778
43. C.A. Skolnick, R.G. Fiscella, and H.H. Tessler Tissue plasminogen activator to treat impending pupillary block glaucoma in patients with acute fibrinous HLA-B27 positive iridocyclitis Am J Ophthalmol 129 3 2000 363 366
44. T. Akingbehin, and J.R. Villada Metipranolol-associated granulomatous anterior uveitis Br J Ophthalmol 75 9 1991 519 523
45. T. Akingbehin, and J.R. Villada Metipranolol-induced adverse reactions: II. Loss of intraocular pressure control Eye 6 Pt 3 1992 280 283
46. T. Akingbehin, J.R. Villada, and T. Walley Metipranolol-induced adverse reactions: I. The rechallenge study Eye 6 Pt 3 1992 277 279
47. N.P. Patel, K.H. Patel, and M.R. Moster Metipranolol-associated nongranulomatous anterior uveitis Am J Ophthalmol 123 6 1997 843 844
48. G.R. O'Connor Granulomatous uveitis and metipranolol Br J Ophthalmol 77 8 1993 536 538
49. D.B. Byles, P. Frith, and J.F. Salmon Anterior uveitis as a side effect of topical brimonidine Am J Ophthalmol 130 3 2000 287 291
50. R.A. Schumer, C.B. Camras, and A.K. Mandahl Putative side effects of prostaglandin analogs Surv Ophthalmol 47 Suppl 1 2002 S219
51. A. Alm, and J. Stjernschantz Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group Ophthalmology 102 12 1995 1743 1752
52. C.B. Camras Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group Ophthalmology 103 1 1996 138 147
53. C.B. Camras, A. Alm, and P. Watson Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups Ophthalmology 103 11 1996 1916 1924
54. H.K. Mishima, K. Masuda, and Y. Kitazawa A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study Arch Ophthalmol 114 8 1996 929 932
55. K. Miyake, and N. Ibaraki Prostaglandins and cystoid macular edema Surv Ophthalmol 47 Suppl 1 2002 S203 S218
56. K. Miyake, I. Ota, and N. Ibaraki Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia Arch Ophthalmol 119 3 2001 387 394
57. P. Watson, and J. Stjernschantz A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group Ophthalmology 103 1 1996 126 137
58. V.C. Sung, and K. Barton Management of inflammatory glaucomas Curr Opin Ophthalmol 15 2 2004 136 140
59. S.P. Srinivas, A. Ong, and C.B. Zhai Inhibition of carbonic anhydrase activity in cultured bovine corneal endothelial cells by dorzolamide Invest Ophthalmol Vis Sci 43 10 2002 3273 3278
60. A. Konowal, J.C. Morrison, and S.V. Brown Irreversible corneal decompensation in patients treated with topical dorzolamide Am J Ophthalmol 127 4 1999 403 406
61. I. Adamsons Irreversible corneal decompensation in patients treated with topical dorzolamide Am J Ophthalmol 128 6 1999 774 776
62. P. Stavrou, and P.I. Murray Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis Am J Ophthalmol 128 4 1999 434 439
63. H.M. Towler, P. McCluskey, and B. Shaer Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma Ophthalmology 107 10 2000 1822 1828
64. H.D. Jampel, D.A. Jabs, and H.A. Quigley Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma Am J Ophthalmol 109 2 1990 168 173
65. C.J. Patitsas, E.J. Rockwood, and D.M. Meisler Glaucoma filtering surgery with postoperative 5-fluorouracil in patients with intraocular inflammatory disease Ophthalmology 99 4 1992 594 599
66. A.C. Molteno, K.W. Whittaker, and T.H. Bevin Otago Glaucoma Surgery Outcome Study: long term results of cataract extraction combined with Molteno implant insertion or trabeculectomy in primary glaucoma Br J Ophthalmol 88 1 2004 32 35
67. M.R. Wilson, U. Mendis, and S.D. Smith Ahmed glaucoma valve implant vs. trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial Am J Ophthalmol 130 3 2000 267 273
68. M.R. Wilson, U. Mendis, and A. Paliwal Long-term follow-up of primary glaucoma surgery with Ahmed glaucoma valve implant versus trabeculectomy Am J Ophthalmol 136 3 2003 464 470
69. R.D. Jager, L.P. Aiello, and S.C. Patel Risks of intravitreous injection: a comprehensive review Retina 24 5 2004 676 698
70. R.G. Carassa, P. Bettin, and M. Fiori Viscocanalostomy versus trabeculectomy in white adults affected by open-angle glaucoma: a 2-year randomized, controlled trial Ophthalmology 110 5 2003 882 887
71. D.H. Johnson, and M. Johnson How does nonpenetrating glaucoma surgery work? Aqueous outflow resistance and glaucoma surgery J Glaucoma 10 1 2001 55 67
72. M.D. de Smet, F. Gunning, and R. Feenstra The surgical management of chronic hypotony due to uveitis Eye 19 1 2005 60 64
73. C. Auer, A. Mermoud, and C.P. Herbort Deep sclerectomy for the management of uncontrolled uveitic glaucoma: preliminary data Klin Monatsbl Augenheilkd 221 5 2004 339 342
74. C.L. Ho, E.Y. Wong, and D.S. Walton Goniosurgery for glaucoma complicating chronic childhood uveitis Arch Ophthalmol 122 6 2004 838 844